| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Arrowhead Pharmaceuticals, Inc. (ARWR) has 12 insiders with recent SEC Form 4 filings, including 0 buys and 1 sell. ARWR is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 3.79M | $310.91M | - | |
| COO | 473.3K | $38.80M | - | |
| Other | 227.0K | $18.60M | - | |
| CFO | 162.9K | $13.35M | - | |
| Dir | 123.1K | $10.09M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jan 5, 2015 | Lewis David L. | Chief Scientific Officer | Sale+OE | 15,000 | $8.01 | $120,103.50 | -100% |